Detalhe da pesquisa
1.
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study.
Eur Respir J
; 59(2)2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210789
2.
Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data.
Front Pediatr
; 11: 1114207, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911042
3.
Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis.
Clin Rheumatol
; 30(9): 1163-72, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21384257